Artificial intelligence in drug discovery: A new frontier in the fight against Mycobacterium tuberculosis

Drug Discov Today. 2024 Mar;29(3):103909. doi: 10.1016/j.drudis.2024.103909. Epub 2024 Feb 1.

Authors

Mohammad Abavisani¹, Alireza Khoshrou¹, Amirhossein Sahebkar²

Affiliations

¹ Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
² Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: amir_saheb2000@yahoo.com.

PMID: 38307380
DOI: 10.1016/j.drudis.2024.103909

No abstract available

Publication types

Editorial

MeSH terms

Antitubercular Agents / pharmacology
Antitubercular Agents / therapeutic use
Artificial Intelligence
Drug Discovery
Humans
Mycobacterium tuberculosis*
Tuberculosis* / drug therapy
Tuberculosis* / microbiology

Substances

Antitubercular Agents